Pembrolizumab
GCT1046-05
Phase 2 mab terminated
Quick answer
Pembrolizumab for Advanced Endometrial Cancer is a Phase 2 program (mab) at Genmab A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Genmab A/S
- Indication
- Advanced Endometrial Cancer
- Phase
- Phase 2
- Modality
- mab
- Status
- terminated